High-dose carmustine autologous bone marrow reinfusion treatment refractory small cell lung carcinoma Fourteen patients small cell carcinoma lung relapse disease refractory carmustine BCNU doses autologous bone marrow transplantation patients cyclophosphamide doxorubicin vincristine Seven patients high-dose BCNU response confidence limits patients complete response partial response Regrowth tumor days treatment responding patients Death patients recovery platelet count cells/microliters response rate high toxicity excessive dosage range patients BCNU recommended additional investigation patients central nervous system metastases radiation therapy 